Prevalence of quinolone-resistant uropathogenic Escherichia coli in a tertiary care hospital in south Iran

References

• Terlizzi ME, Gribaudo G, Maffei ME. UroPathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Front Microbiol. 2017;8:1566. doi:10.3389/fmicb.2017.0156628861072
   PubMed Web of Science ®Google Scholar
• Hemmati H, Khosravi M, Heidarzadeh A, Hashkavaei P, Refahibakhsh N. Vascular access and survival in hemodialysis patients in Rasht, Iran. Iran J Kidney Dis. 2011;5(1):34–37.21189432
   PubMed Web of Science ®Google Scholar
• John U, Kemper MJ. Urinary tract infections in children after renal transplantation. Pediatr Nephrol. 2009;24(6):1129–1136. doi:10.1007/s00467-007-0690-018197424
   PubMed Web of Science ®Google Scholar
• Tenney J, Hudson N, Alnifaidy H, Li JTC, Fung KH. Risk factors for aquiring multidrug-resistant organisms in urinary tract infections: a systematic literature review. Saudi Pharm J. 2018;26(5):678–684. doi:10.1016/j.jsps.2018.02.02329991911
   PubMed Web of Science ®Google Scholar
• Munita JM, Arias CA. Mechanisms of antibiotic resistance. Microbiol Spectr. 2016;4:2.
   Web of Science ®Google Scholar
• King DE, Malone R, Lilley SH. New classification and update on the quinolone antibiotics. Am Fam Physician. 2000;61(9):2741–2748.10821154
   PubMed Web of Science ®Google Scholar
• Tayebi Z, Heidari H, Kazemian H, Ghafoori SM, Boroumandi S, Houri H. Comparison of quinolone and beta-lactam resistance among Escherichia coli strains isolated from urinary tract infections. Infez Med. 2016;24(4):326–330.28011969
   PubMedGoogle Scholar
• Correia S, Poeta P, Hebraud M, Capelo JL, Igrejas G. Mechanisms of quinolone action and resistance: where do we stand? J Med Microbiol. 2017;66(5):551–559. doi:10.1099/jmm.0.00047528504927
   PubMed Web of Science ®Google Scholar
• Jacoby GA. Mechanisms of resistance to quinolones. Clin Infect Dis. 2005;41(Suppl 2):S120–126. doi:10.1086/44449915942878
   PubMed Web of Science ®Google Scholar
• Ebrahim-Saraie HS, Nezhad NZ, Heidari H, Motamedifar A, Motamedifar M. Detection of antimicrobial susceptibility and integrons among extended-spectrum beta-lactamase producing uropathogenic Escherichia coli isolates in Southwestern Iran. Oman Med J. 2018;33(3):218–223. doi:10.5001/omj.2018.4029896329
   PubMedGoogle Scholar
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing; 28th Informational Supplement. CLSI Document M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2018:2018.
   Google Scholar
• Oktem IM, Gulay Z, Bicmen M, Gur D. qnrA prevalence in extended-spectrum beta-lactamase-positive enterobacteriaceae isolates from Turkey. Jpn J Infect Dis. 2008;61(1):13–17.18219128
   PubMed Web of Science ®Google Scholar
• Nobari S, Shahcheraghi F, Rahmati Ghezelgeh F, Valizadeh B. Molecular characterization of carbapenem-resistant strains of klebsiella pneumoniae isolated from Iranian patients: first identification of blaKPC gene in Iran. Microb Drug Resist. 2014;20(4):285–293. doi:10.1089/mdr.2013.007424428238
   PubMed Web of Science ®Google Scholar
• Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother. 2007;60(2):394–397. doi:10.1093/jac/dkm21517561500
   PubMed Web of Science ®Google Scholar
• McQuiston Haslund J, Rosborg Dinesen M, Sternhagen Nielsen AB, Llor C, Bjerrum L. Different recommendations for empiric first-choice antibiotic treatment of uncomplicated urinary tract infections in Europe. Scand J Prim Health Care. 2013;31(4):235–240. doi:10.3109/02813432.2013.84441024102498
   PubMed Web of Science ®Google Scholar
• Bidell MR, Palchak M, Mohr J, Lodise TP. Fluoroquinolone and third-generation-cephalosporin resistance among hospitalized patients with urinary tract infections due to Escherichia coli: do rates vary by hospital characteristics and geographic region? Antimicrob Agents Chemother. 2016;60(5):3170–3173. doi:10.1128/AAC.02505-1526926640
   PubMed Web of Science ®Google Scholar
• Kim ES, Hooper DC. Clinical importance and epidemiology of quinolone resistance. Infect Chemother. 2014;46(4):226–238. doi:10.3947/ic.2014.46.4.22625566402
   PubMedGoogle Scholar
• Bryce A, Hay AD, Lane IF, Thornton HV, Wootton M, Costelloe C. Global prevalence of antibiotic resistance in paediatric urinary tract infections caused by Escherichia coli and association with routine use of antibiotics in primary care: systematic review and meta-analysis. Bmj. 2016;352:i939. doi:10.1136/bmj.i171726980184
   PubMed Web of Science ®Google Scholar
• Carson C, Naber KG. Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections. Drugs. 2004;64(12):1359–1373. doi:10.2165/00003495-200464120-0000715200349
   PubMed Web of Science ®Google Scholar
• Shah A, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN. Application of fluoroquinolone resistance score in management of complicated urinary tract infections. Antimicrob Agents Chemother. 2017;61:5. doi:10.1128/AAC.02313-16
   Web of Science ®Google Scholar
• Pouladfar G, Basiratnia M, Anvarinejad M, Abbasi P, Amirmoezi F, Zare S. The antibiotic susceptibility patterns of uropathogens among children with urinary tract infection in Shiraz. Medicine (Baltimore). 2017;96(37):e7834. doi:10.1097/MD.000000000000783428906365
   PubMed Web of Science ®Google Scholar
• Shenagari M, Bakhtiari M, Mojtahedi A, Atrkar Roushan Z. High frequency of mutations in gyrA gene associated with quinolones resistance in uropathogenic Escherichia coli isolates from the north of Iran. Iran J Basic Med Sci. 2018;21(12):1226–1231.30627365
   PubMed Web of Science ®Google Scholar
• Rezazadeh M, Baghchesaraei H, Peymani A. Plasmid-mediated quinolone-resistance (qnr) genes in clinical isolates of Escherichia coli collected from several hospitals of Qazvin and Zanjan Provinces, Iran. Osong Public Health Res Perspect. 2016;7(5):307–312. doi:10.1016/j.phrp.2016.08.00327812489
   PubMedGoogle Scholar
• Damavandi MS, Gholipour A, Latif Pour M. Prevalence of class D carbapenemases among extended-spectrum beta-lactamases producing Escherichia coli isolates from educational hospitals in Shahrekord. J Clin Diagn Res. 2016;10(5):Dc01–05.
   Google Scholar
• Sedighi I, Arabestani MR, Rahimbakhsh A, Karimitabar Z, Alikhani MY. Dissemination of extended-spectrum beta-lactamases and quinolone resistance genes among clinical isolates of uropathogenic Escherichia coli in children. Jundishapur J Microbiol. 2015;8(7):e19184. doi:10.5812/jjm.19184v226421128
   PubMed Web of Science ®Google Scholar
• Fasugba O, Gardner A, Mitchell BG, Mnatzaganian G. Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies. BMC Infect Dis. 2015;15:545. doi:10.1186/s12879-015-1282-426607324
   PubMed Web of Science ®Google Scholar
• McNally A, Kallonen T, Connor C, et al. Diversification of colonization factors in a multidrug-resistant Escherichia coli lineage evolving under negative frequency-dependent selection. MBio. 2019;10(2):e00644–00619. doi:10.1128/mBio.00669-1931015329
   PubMed Web of Science ®Google Scholar
• Hojabri Z, Mirmohammadkhani M, Kamali F, Ghassemi K, Taghavipour S, Pajand O. Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran. Eur J Clin Microbiol Infect Dis. 2017;36(10):1859–1866. doi:10.1007/s10096-017-3021-928550370
   PubMed Web of Science ®Google Scholar
• Moghanni M, Ghazvini K, Farsiani H, et al. High prevalence of sequence type 131 isolates producing CTX-M-15 among extended-spectrum beta-lactamase-producing Escherichia coli strains in northeast Iran. J Glob Antimicrob Resist. 2018;15:74–78. doi:10.1016/j.jgar.2018.05.01629807202
   PubMed Web of Science ®Google Scholar
• Namaei MH, Yousefi M, Ziaee M, et al. First Report of prevalence of CTX-M-15-producing Escherichia coli O25b/ST131 from Iran. Microb Drug Resist. 2017;23(7):879–884. doi:10.1089/mdr.2016.006928437226
   PubMed Web of Science ®Google Scholar
• Badran EF, Qamer Din RA, Shehabi AA. Low intestinal colonization of Escherichia coli clone ST131 producing CTX-M-15 in Jordanian infants. J Med Microbiol. 2016;65(2):137–141. doi:10.1099/jmm.0.00021026690259
   PubMed Web of Science ®Google Scholar
• Jacoby GA, Strahilevitz J, Hooper DC. Plasmid-mediated quinolone resistance. Microbiol Spectr. 2014;2:5. doi:10.1128/microbiolspec.PLAS-0006-2013
   Google Scholar
• Yousefi S, Mojtahedi A, Shenagari MA. Survey of gyrA target-site mutation and qnr genes among clinical isolates of Escherichia coli in the North of Iran. Jundishapur J Microbiol. 2018;11(9):e67293. doi:10.5812/jjm.67293
   Web of Science ®Google Scholar
• Abbasi H, Ranjbar R. The prevalence of quinolone resistance genes of A, B, S in Escherichia coli strains isolated from three major hospitals in Tehran, Iran. Cent European J Urol. 2018;71(1):129–133.
   Web of Science ®Google Scholar
• Al-Hasnawy HH, Jodi MR, Hamza HJ. Molecular characterization and sequence analysis of plasmid-mediated quinolone resistance genes in extended-spectrum beta-lactamases producing uropathogenic Escherichia coli in Babylon Province, Iraq. Rev Med Microbiol. 2018;29(3):129–135. doi:10.1097/MRM.0000000000000136
   Web of Science ®Google Scholar
• Ali I, Rafaque Z, Ahmed S, Malik S, Dasti JI. Prevalence of multi-drug resistant uropathogenic Escherichia coli in Potohar region of Pakistan. Asian Pac J Trop Biomed. 2016;6(1):60–66. doi:10.1016/j.apjtb.2015.09.022
   Web of Science ®Google Scholar
• Al-Agamy MH, Aljallal A, Radwan HH, Shibl AM. Characterization of carbapenemases, ESBLs, and plasmid-mediated quinolone determinants in carbapenem-insensitive Escherichia coli and Klebsiella pneumoniae in Riyadh hospitals. J Infect Public Health. 2018;11(1):64–68. doi:10.1016/j.jiph.2017.03.01028462854
   PubMed Web of Science ®Google Scholar
• Shin JH, Jung HJ, Lee JY, Kim HR, Lee JN, Chang CL. High rates of plasmid-mediated quinolone resistance QnrB variants among ciprofloxacin-resistant Escherichia coli and Klebsiella pneumoniae from urinary tract infections in Korea. Microb Drug Resist. 2008;14(3):221–226. doi:10.1089/mdr.2008.083418707554
   PubMed Web of Science ®Google Scholar
• Kao CY, Wu HM, Lin WH, et al. Plasmid-mediated quinolone resistance determinants in quinolone-resistant Escherichia coli isolated from patients with bacteremia in a university hospital in Taiwan, 2001–2015. Sci Rep. 2016;6:32281. doi:10.1038/srep3228127573927
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhang J, Zheng B, et al. Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals. J Clin Microbiol. 2015;53(3):766–770. doi:10.1128/JCM.02594-1425520451
   PubMed Web of Science ®Google Scholar